1
|
Scuteri A, Laurent S, Cucca F, Cockcroft
J, Cunha PG, Mañas LR, Mattace Raso FU, Muiesan ML, Ryliškytė L,
Rietzschel E, et al: Metabolic Syndrome and Arteries Research
(MARE) Consortium: Metabolic syndrome across Europe: Different
clusters of risk factors. Eur J Prev Cardiol. 22:486–491. 2015.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Moore JX, Chaudhary N and Akinyemiju T:
Metabolic syndrome prevalence by race/ethnicity and sex in the
United States, National Health and Nutrition Examination Survey,
1988–2012. Prev Chronic Dis. 14:E242017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kaur J: A comprehensive review on
metabolic syndrome. Cardiol Res Pract. 2014:9431622014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Felizola SJA: Ursolic acid in experimental
models and human subjects: Potential as an anti-obesity/overweight
treatment? doi: 10.13140/RG.2.1.4502.4804. 2015
|
5
|
de Sousa SM and Norman RJ: Metabolic
syndrome, diet and exercise. Best Pract Res Clin Obstet Gynaecol.
37:140–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Root MM and Dawson HR: DASH-like diets
high in protein or monounsaturated fats improve metabolic syndrome
and calculated vascular risk. Int J Vitam Nutr Res. 83:224–231.
2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sofer S, Stark AH and Madar Z: Nutrition
targeting by food timing: Time-related dietary approaches to combat
obesity and metabolic syndrome. Adv Nutr. 6:214–223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Halliwell B: The wanderings of a free
radical. Free Radic Biol Med. 46:531–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ghosh J and Myers CE: Inhibition of
arachidonate 5-lipoxygenase triggers massive apoptosis in human
prostate cancer cells. Proc Natl Acad Sci USA. 95:13182–13187.
1998. View Article : Google Scholar : PubMed/NCBI
|
10
|
Valko M, Leibfritz D, Moncol J, Cronin MT,
Mazur M and Telser J: Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem Cell Biol.
39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Orient A, Donkó A, Szabó A, Leto TL and
Geiszt M: Novel sources of reactive oxygen species in the human
body. Nephrol Dial Transplant. 22:1281–1288. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mylonas C and Kouretas D: Lipid
peroxidation and tissue damage. In Vivo. 13:295–309.
1999.PubMed/NCBI
|
13
|
Nikooyeh B and Neyestani TR: Oxidative
stress, type 2 diabetes and vitamin D: Past, present and future.
Diabetes Metab Res Rev. 32:260–267. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Folli F, Corradi D, Fanti P, Davalli A,
Paez A, Giaccari A, Perego C and Muscogiuri G: The role of
oxidative stress in the pathogenesis of type 2 diabetes mellitus
micro- and macrovascular complications: Avenues for a
mechanistic-based therapeutic approach. Curr Diabetes Rev.
7:313–324. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ha CY, Kim JY, Paik JK, Kim OY, Paik YH,
Lee EJ and Lee JH: The association of specific metabolites of lipid
metabolism with markers of oxidative stress, inflammation and
arterial stiffness in men with newly diagnosed type 2 diabetes.
Clin Endocrinol (Oxf). 76:674–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Aroor AR and DeMarco VG: Oxidative stress
and obesity: The chicken or the egg? Diabetes. 63:2216–2218. 2014.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Spanidis Y, Mpesios A, Stagos D,
Goutzourelas N, Bar-Or D, Karapetsa M, Zakynthinos E, Spandidos DA,
Tsatsakis AM, Leon G and Kouretas D: Assessment of the redox status
in patients with metabolic syndrome and type 2 diabetes reveals
great variations. Exp Ther Med. 11:895–903. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Sarma S and Levine BD: Beyond the Bruce
Protocol: Advanced Exercise Testing for the Sports Cardiologist.
Cardiol Clin. 34:603–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Keles MS, Taysi S, Sen N, Aksoy H and
Akçay F: Effect of corticosteroid therapy on serum and CSF
malondialdehyde and antioxidant proteins in multiple sclerosis. Can
J Neurol Sci. 28:141–143. 2001. View Article : Google Scholar : PubMed/NCBI
|
21
|
Patsoukis N, Zervoudakis G, Panagopoulos
NT, Georgiou CD, Angelatou F and Matsokis NA: Thiol redox state
(TRS) and oxidative stress in the mouse hippocampus after
pentylenetetrazol-induced epileptic seizure. Neurosci Lett.
357:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Reddy YN, Murthy SV, Krishna DR and
Prabhakar MC: Role of free radicals and antioxidants in
tuberculosis patients. Indian J Tuberc. 51:213–218. 2004.
|
23
|
Stagos D, Goutzourelas N, Ntontou AM,
Kafantaris I, Deli CK, Poulios A, Jamurtas AZ, Bar-Or D and
Kouretas D: Assessment of eccentric exercise-induced oxidative
stress using oxidation-reduction potential markers. Oxid Med Cell
Longev. 2015:2046152015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bloomer RJ and Fisher-Wellman KH: Blood
oxidative stress biomarkers: Influence of sex, exercise training
status, and dietary intake. Gend Med. 5:218–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Deponte M: Glutathione catalysis and the
reaction mechanisms of glutathione-dependent enzymes. Biochim
Biophys Acta. 1830:3217–3266. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wilson PWF and Grundy SM: The metabolic
syndrome: practical guide to origins and treatment: Part I.
Circulation. 108:1422–1424. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Balkau B, Charles MA, Drivsholm T,
Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van
Dam R, Feskins E, et al: European Group For The Study Of Insulin
Resistance (EGIR): Frequency of the WHO metabolic syndrome in
European cohorts, and an alternative definition of an insulin
resistance syndrome. Diabetes Metab. 28:364–376. 2002.PubMed/NCBI
|
28
|
Bulló M, Cózar-Torrell P and Salas-Salvadó
J: Dietary regulation of glucose metabolism in metabolic syndrome.
Curr Vasc Pharmacol. 11:928–945. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Roberts CK, Hevener AL and Barnard RJ:
Metabolic syndrome and insulin resistance: Underlying causes and
modification by exercise training. Compr Physiol. 3:1–58.
2013.PubMed/NCBI
|
30
|
Bouret S, Levin BE and Ozanne SE:
Gene-environment interactions controlling energy and glucose
homeostasis and the developmental origins of obesity. Physiol Rev.
95:47–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Adamo KB, Ferraro ZM and Brett KE: Can we
modify the intrauterine environment to halt the intergenerational
cycle of obesity? Int J Environ Res Public Health. 9:1263–1307.
2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Keane D, Kelly S, Healy NP, McArdle MA,
Holohan K and Roche HM: Diet and metabolic syndrome: An overview.
Curr Vasc Pharmacol. 11:842–857. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Sutin AR, Costa PT Jr, Uda M, Ferrucci L,
Schlessinger D and Terracciano A: Personality and metabolic
syndrome. Age (Dordr). 32:513–519. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ferland A and Eckel RH: Does sustained
weight loss reverse the metabolic syndrome? Curr Hypertens Rep.
13:456–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
35
|
Ades PA and Savage PD: Potential benefits
of weight loss in coronary heart disease. Prog Cardiovasc Dis.
56:448–456. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Abete I, Astrup A, Martínez JA,
Thorsdottir I and Zulet MA: Obesity and the metabolic syndrome:
Role of different dietary macronutrient distribution patterns and
specific nutritional components on weight loss and maintenance.
Nutr Rev. 68:214–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Strasser B: Physical activity in obesity
and metabolic syndrome. Ann N Y Acad Sci. 1281:141–159. 2013.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Emili A, Abushomar H and Nair K: Treating
metabolic syndrome: Lifestyle change or medication? Can Fam
Physician. 53:1203–1205. 2007.PubMed/NCBI
|
39
|
Wikner C, Gigante B, Hellénius ML, de
Faire U and Leander K: The risk of type 2 diabetes in men is
synergistically affected by parental history of diabetes and
overweight. PLoS One. 8:e617632013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Thangavel N, Al Bratty M, Akhtar Javed S,
Ahsan W and Alhazmi HA: Targeting peroxisome proliferator-activated
receptors using thiazolidinediones: Strategy for design of novel
antidiabetic drugs. Int J Med Chem. 2017:10697182017.PubMed/NCBI
|
41
|
Hutcheson R and Rocic P: The metabolic
syndrome, oxidative stress, environment, and cardiovascular
disease: The great exploration. Exp Diabetes Res. 2012:2710282012.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Neyestani TR, Shariatzadeh N, Gharavi A,
Kalayi A and Khalaji N: Physiological dose of lycopene suppressed
oxidative stress and enhanced serum levels of immunoglobulin M in
patients with type 2 diabetes mellitus: A possible role in the
prevention of long-term complications. J Endocrinol Invest.
30:833–838. 2007. View Article : Google Scholar : PubMed/NCBI
|
43
|
Akbar S, Bellary S and Griffiths HR:
Dietary antioxidant interventions in type 2 diabetes patients: A
meta-analysis. Br J Diabetes Vasc Dis. 11:62–68. 2011. View Article : Google Scholar
|
44
|
Spanidis Y, Goutzourelas N, Stagos D,
Kolyva AS, Gogos CA, Bar-Or D and Kouretas D: Assessment of
oxidative stress in septic and obese patients using markers of
oxidation-reduction potential. In Vivo. 29:595–600. 2015.PubMed/NCBI
|
45
|
Kolyva AS, Zolota V, Mpatsoulis D,
Skroubis G, Solomou EE, Habeos IG, Assimakopoulos SF, Goutzourelas
N, Kouretas D and Gogos CA: The role of obesity in the immune
response during sepsis. Nutr Diabetes. 4:e1372014. View Article : Google Scholar : PubMed/NCBI
|
46
|
Mazzetti AP, Fiorile MC, Primavera A and
Lo Bello M: Glutathione transferases and neurodegenerative
diseases. Neurochem Int. 82:10–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
47
|
Pérez S, Pereda J, Sabater L and Sastre J:
Redox signaling in acute pancreatitis. Redox Biol. 5:1–14. 2015.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Nogiec C, Burkart A, Dreyfuss JM, Lerin C,
Kasif S and Patti ME: Metabolic modeling of muscle metabolism
identifies key reactions linked to insulin resistance phenotypes.
Mol Metab. 4:151–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
49
|
Jumpertz R, Guijarro A, Pratley RE, Mason
CC, Piomelli D and Krakoff J: Associations of fatty acids in
cerebrospinal fluid with peripheral glucose concentrations and
energy metabolism. PLoS One. 7:e415032012. View Article : Google Scholar : PubMed/NCBI
|
50
|
Findeisen HM, Gizard F, Zhao Y, Qing H,
Jones KL, Cohn D, Heywood EB and Bruemmer D: Glutathione depletion
prevents diet-induced obesity and enhances insulin sensitivity.
Obesity (Silver Spring). 19:2429–2432. 2011. View Article : Google Scholar : PubMed/NCBI
|
51
|
Picklo MJ, Long EK and Vomhof-DeKrey EE:
Glutathionyl systems and metabolic dysfunction in obesity. Nutr
Rev. 73:858–868. 2015. View Article : Google Scholar : PubMed/NCBI
|
52
|
Vomhof-Dekrey EE and Picklo MJ Sr: The
Nrf2-antioxidant response element pathway: A target for regulating
energy metabolism. J Nutr Biochem. 23:1201–1206. 2012. View Article : Google Scholar : PubMed/NCBI
|
53
|
Seo HA and Lee IK: The role of Nrf2:
Adipocyte differentiation, obesity, and insulin resistance. Oxid
Med Cell Longev. 2013:1845982013. View Article : Google Scholar : PubMed/NCBI
|
54
|
Jiménez-Osorio AS, Picazo A,
González-Reyes S, Barrera-Oviedo D, Rodríguez-Arellano ME and
Pedraza-Chaverri J: Nrf2 and redox status in prediabetic and
diabetic patients. Int J Mol Sci. 15:20290–20305. 2014. View Article : Google Scholar : PubMed/NCBI
|
55
|
Liu X and Fang F: Type 2 diabetes caused
by reductive redox potential? Sci China Life Sci. 57:729–730. 2014.
View Article : Google Scholar : PubMed/NCBI
|
56
|
Erol A: Type 2 diabetes and cancer as
redox diseases? Lancet. 384:853–854. 2014. View Article : Google Scholar : PubMed/NCBI
|
57
|
Watson JD: Type 2 diabetes as a redox
disease. Lancet. 383:841–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
58
|
Kendig EL, Chen Y, Krishan M, Johansson E,
Schneider SN, Genter MB, Nebert DW and Shertzer HG: Lipid
metabolism and body composition in Gclm(−/-) mice. Toxicol Appl
Pharmacol. 257:338–348. 2011. View Article : Google Scholar : PubMed/NCBI
|
59
|
Griffith OW and Meister A: Potent and
specific inhibition of glutathione synthesis by buthionine
sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem.
254:7558–7560. 1979.PubMed/NCBI
|
60
|
Lin AH, Chen HW, Liu CT, Tsai CW and Lii
CK: Activation of Nrf2 is required for up-regulation of the π class
of glutathione S-transferase in rat primary hepatocytes with
L-methionine starvation. J Agric Food Chem. 60:6537–6545. 2012.
View Article : Google Scholar : PubMed/NCBI
|
61
|
Pi J, Leung L, Xue P, Wang W, Hou Y, Liu
D, Yehuda-Shnaidman E, Lee C, Lau J, Kurtz TW, et al: Deficiency in
the nuclear factor E2-related factor-2 transcription factor results
in impaired adipogenesis and protects against diet-induced obesity.
J Biol Chem. 285:9292–9300. 2010. View Article : Google Scholar : PubMed/NCBI
|
62
|
Shehzad A, Ha T, Subhan F and Lee YS: New
mechanisms and the anti-inflammatory role of curcumin in obesity
and obesity-related metabolic diseases. Eur J Nutr. 50:151–161.
2011. View Article : Google Scholar : PubMed/NCBI
|
63
|
Shibata T, Kimura Y, Mukai A, Mori H, Ito
S, Asaka Y, Oe S, Tanaka H, Takahashi T and Uchida K:
Transthiocarbamoylation of proteins by thiolated isothiocyanates. J
Biol Chem. 286:42150–42161. 2011. View Article : Google Scholar : PubMed/NCBI
|
64
|
McClung JP, Roneker CA, Mu W, Lisk DJ,
Langlais P, Liu F and Lei XG: Development of insulin resistance and
obesity in mice overexpressing cellular glutathione peroxidase.
Proc Natl Acad Sci USA. 101:8852–8857. 2004. View Article : Google Scholar : PubMed/NCBI
|
65
|
Wang X, Vatamaniuk MZ, Roneker CA, Pepper
MP, Hu LG, Simmons RA and Lei XG: Knockouts of SOD1 and GPX1 exert
different impacts on murine islet function and pancreatic
integrity. Antioxid Redox Signal. 14:391–401. 2011. View Article : Google Scholar : PubMed/NCBI
|
66
|
Wang XD, Vatamaniuk MZ, Wang SK, Roneker
CA, Simmons RA and Lei XG: Molecular mechanisms for
hyperinsulinaemia induced by overproduction of selenium-dependent
glutathione peroxidase-1 in mice. Diabetologia. 51:1515–1524. 2008.
View Article : Google Scholar : PubMed/NCBI
|
67
|
Kuzuya M, Ando F, Iguchi A and Shimokata
H: Glutathione peroxidase 1 Pro198Leu variant contributes to the
metabolic syndrome in men in a large Japanese cohort. Am J Clin
Nutr. 87:1939–1944. 2008. View Article : Google Scholar : PubMed/NCBI
|
68
|
Applegate MA, Humphries KM and Szweda LI:
Reversible inhibition of alpha-ketoglutarate dehydrogenase by
hydrogen peroxide: Glutathionylation and protection of lipoic acid.
Biochemistry. 47:473–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
69
|
Kil IS and Park JW: Regulation of
mitochondrial NADP+-dependent isocitrate dehydrogenase
activity by glutathionylation. J Biol Chem. 280:10846–10854. 2005.
View Article : Google Scholar : PubMed/NCBI
|
70
|
McLain AL, Cormier PJ, Kinter M and Szweda
LI: Glutathionylation of α-ketoglutarate dehydrogenase: The
chemical nature and relative susceptibility of the cofactor lipoic
acid to modification. Free Radic Biol Med. 61:161–169. 2013.
View Article : Google Scholar : PubMed/NCBI
|
71
|
Bid HK, Konwar R, Saxena M, Chaudhari P,
Agrawal CG and Banerjee M: Association of glutathione S-transferase
(GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus
in north Indian population. J Postgrad Med. 56:176–181. 2010.
View Article : Google Scholar : PubMed/NCBI
|
72
|
Tang ST, Wang CJ, Tang HQ, Zhang Q and
Wang Y: Evaluation of glutathione S-transferase genetic variants
affecting type 2 diabetes susceptibility: A meta-analysis. Gene.
530:301–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
73
|
Matthaiou CM, Goutzourelas N, Stagos D,
Sarafoglou E, Jamurtas A, Koulocheri SD, Haroutounian SA, Tsatsakis
AM and Kouretas D: Pomegranate juice consumption increases GSH
levels and reduces lipid and protein oxidation in human blood. Food
Chem Toxicol. 73:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
74
|
Samaras A, Tsarouhas K, Paschalidis E,
Giamouzis G, Triposkiadis F, Tsitsimpikou C, Becker AT,
Goutzourelas N and Kouretas D: Effect of a special
carbohydrate-protein bar and tomato juice supplementation on
oxidative stress markers and vascular endothelial dynamics in
ultra-marathon runners. Food Chem Toxicol. 69:231–236. 2014.
View Article : Google Scholar : PubMed/NCBI
|